These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 11007887)
21. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium. Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999 [TBL] [Abstract][Full Text] [Related]
22. Electron microscopic immunolabeling of transporters and receptors identifies transmitter-specific functional sites envisioned in Cajal's neuron. Pickel VM; Garzón M; Mengual E Prog Brain Res; 2002; 136():145-55. PubMed ID: 12143378 [TBL] [Abstract][Full Text] [Related]
23. Protein kinase C-mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells. Shoji-Kasai Y; Itakura M; Kataoka M; Yamamori S; Takahashi M Eur J Neurosci; 2002 Apr; 15(8):1390-4. PubMed ID: 11994133 [TBL] [Abstract][Full Text] [Related]
24. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. Liu Y; Schweitzer ES; Nirenberg MJ; Pickel VM; Evans CJ; Edwards RH J Cell Biol; 1994 Dec; 127(5):1419-33. PubMed ID: 7962100 [TBL] [Abstract][Full Text] [Related]
25. The neuronal monoamine transporter VMAT2 is regulated by the trimeric GTPase Go(2). Höltje M; von Jagow B; Pahner I; Lautenschlager M; Hörtnagl H; Nürnberg B; Jahn R; Ahnert-Hilger G J Neurosci; 2000 Mar; 20(6):2131-41. PubMed ID: 10704487 [TBL] [Abstract][Full Text] [Related]
26. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors. Duerr JS; Frisby DL; Gaskin J; Duke A; Asermely K; Huddleston D; Eiden LE; Rand JB J Neurosci; 1999 Jan; 19(1):72-84. PubMed ID: 9870940 [TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of vesicular amine transporter function and targeting to secretory organelles. Erickson JD; Varoqui H FASEB J; 2000 Dec; 14(15):2450-8. PubMed ID: 11099462 [TBL] [Abstract][Full Text] [Related]
28. VMAT-Mediated changes in quantal size and vesicular volume. Colliver TL; Pyott SJ; Achalabun M; Ewing AG J Neurosci; 2000 Jul; 20(14):5276-82. PubMed ID: 10884311 [TBL] [Abstract][Full Text] [Related]
29. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of dopamine quantal size regulation. Pereira DB; Sulzer D Front Biosci (Landmark Ed); 2012 Jun; 17(7):2740-67. PubMed ID: 22652810 [TBL] [Abstract][Full Text] [Related]
31. Spike Activity Regulates Vesicle Filling at a Glutamatergic Synapse. Li D; Zhu Y; Huang H J Neurosci; 2020 Jun; 40(26):4972-4980. PubMed ID: 32430294 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata. Staal RG; Sonsalla PK J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000 [TBL] [Abstract][Full Text] [Related]
33. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Fon EA; Pothos EN; Sun BC; Killeen N; Sulzer D; Edwards RH Neuron; 1997 Dec; 19(6):1271-83. PubMed ID: 9427250 [TBL] [Abstract][Full Text] [Related]
35. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Jaber M; Dumartin B; Sagné C; Haycock JW; Roubert C; Giros B; Bloch B; Caron MG Eur J Neurosci; 1999 Oct; 11(10):3499-511. PubMed ID: 10564358 [TBL] [Abstract][Full Text] [Related]
36. Targeting exocytosis: ins and outs of the modulation of quantal dopamine release. Westerink RH CNS Neurol Disord Drug Targets; 2006 Feb; 5(1):57-77. PubMed ID: 16613554 [TBL] [Abstract][Full Text] [Related]
37. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture. Yamamoto H; Kamegaya E; Hagino Y; Imai K; Fujikawa A; Tamura K; Enokiya T; Yamamoto T; Takeshima T; Koga H; Uhl GR; Ikeda K; Sora I Neurochem Int; 2007; 51(2-4):237-44. PubMed ID: 17664021 [TBL] [Abstract][Full Text] [Related]
38. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. Riddle EL; Topham MK; Haycock JW; Hanson GR; Fleckenstein AE Eur J Pharmacol; 2002 Aug; 449(1-2):71-4. PubMed ID: 12163108 [TBL] [Abstract][Full Text] [Related]
39. Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content. Daniels RW; Collins CA; Gelfand MV; Dant J; Brooks ES; Krantz DE; DiAntonio A J Neurosci; 2004 Nov; 24(46):10466-74. PubMed ID: 15548661 [TBL] [Abstract][Full Text] [Related]